Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Double Trouble: Composite Mutations in Driver Genes in Acute Myeloid Leukemia (AML)

Blood (2024) 144 (Supplement 1): 2931.

https://doi.org/10.1182/blood-2024-199348

Published: 2024

Journal Articles

Making Treatment Free Remission “Feasible” in Low- and Middle- Income Countries - Outcomes, Patterns of Failure and Compliance of Treatment Free Remission (TFR) in Chronic Myeloid Leukemia (CML) from a Tertiary Care Cancer Centre in India

Sachin Punatar, Nishant Jindal, Anant Gokarn, Sumeet Mirgh, Akanksha Chichra, Lingaraj Nayak, Bhausaheb Bagal, Vinod Hande, Swapnil Chavan, Komal Kumbhalwar, Hari Menon, Navin Khattry

Blood (2024) 144 (Supplement 1): 3161.

https://doi.org/10.1182/blood-2024-209885

Published: 2024

Journal Articles

Real World Data of Novel Talicabtagene Autoleucel (humanized CD19 CAR-T) from India; Ensuring Equitable Access with Excellent Safety and Efficacy Profile

Blood (2024) 144 (Supplement 1): 3755.

https://doi.org/10.1182/blood-2024-202335

Published: 2024

Journal Articles

Leukemic Stem Cell Measurable Residual Disease (LSC MRD) Status Is a Better Predictor of Relapse Than Multiparametric Flowcytometric Analysis in Acute Myeloid Leukemia Patients

Blood (2024) 144 (Supplement 1): 2953.

https://doi.org/10.1182/blood-2024-199036

Published: 2024

Journal Articles

Machine Learning Identifies Gene Mutations and Variant Allele Fractions That Refine the 2022 European Leukemianet Risk Stratification for Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 852.

https://doi.org/10.1182/blood-2024-193534

Published: 2024

Journal Articles

Diagnostic Value, Predictive Significance and Kinetics of Fecal Calprotectin in Suspected Acute Gut Gvhd / Gvhd Flare Post Allogeneic Stem Cell Transplant

Sachin Punatar, Lingaraj Nayak, Niket Mantri, Mukta Ramadwar, Prachi Patil, Shaesta Mehta, Aditya Kale, Sridhar Epari, Sridhar Sundaram, Koustubh Shekar, Anant Gokarn, Akanksha Chichra, Sumeet Mirgh, Nishant Jindal, Kalpashree Deval, Libin Jacob Mathew, Bhausaheb Bagal, Hari Menon, Navin Khattry

Blood (2024) 144 (Supplement 1): 4901.

https://doi.org/10.1182/blood-2024-209698

Published: 2024

Journal Articles

Validation of the 2022 European Leukemianet Risk Stratification of Acute Myeloid Leukemia (AML)

Blood (2024) 144 (Supplement 1): 4310.

https://doi.org/10.1182/blood-2024-199045

Published: 2024

Journal Articles

Mutational Landscape and Factors Affecting Prognosis in Acute Myeloid Leukaemia (AML) with RUNX1::RUNX1T1

Blood (2024) 144 (Supplement 1): 4290.

https://doi.org/10.1182/blood-2024-199037

Published: 2024

Journal Articles

Prognostic Significance of Wilms' Tumor 1 Gene Mutations in Acute Myeloid Leukemia: Risk Stratification and Survival Outcomes

Blood (2024) 144 (Supplement 1): 1550.

https://doi.org/10.1182/blood-2024-199066

Published: 2024

Journal Articles

Myelodysplasia-Related Mutations in Adults and End-of-Induction Measurable Residual Disease Are Associated with Inferior Outcome in Patients with Acute Leukemia of Ambiguous Lineage

Blood (2024) 144 (Supplement 1): 6095.

https://doi.org/10.1182/blood-2024-202253

Published: 2024

Journal Articles

Quantitation of Leukemic Stem Cell-like Cells (LSC) Burden at Diagnosis Identifies Clinical Heterogeneity in the ELN22 Risk Stratification of Acute Myeloid Leukemia (AML)

Blood (2024) 144 (Supplement 1): 6088.

https://doi.org/10.1182/blood-2024-199067

Published: 2024

Journal Articles

NPM1 Mutated AML with Concurrent DNMT3A Mutation, and FLT3 -Internal Tandem Duplication Has Outcomes Similar to European Leukemianet Adverse Risk Category

Blood (2024) 144 (Supplement 1): 6087.

https://doi.org/10.1182/blood-2024-199065

Published: 2024

Journal Articles

Early Immune Reconstitution Post Allogeneic Transplant and Its Impact on Outcomes According to Type of Transplant

Saswata Saha, Disha Jain, Prashant Tembhare, Nishant Jindal, Puja Ramchandra Bhuibhar, Libin Jacob Mathew, Sumeet Mirgh, Akanksha Chichra, Lingaraj Nayak, Anant Gokarn, Sachin Punatar, Bhausaheb Bagal, Sweta Rajpal, Gaurav Chatterjee, Nikhil Patkar, Papagudi Ganesan Subramanian, Hari Menon, Navin Khattry

Blood (2024) 144 (Supplement 1): 7352.

https://doi.org/10.1182/blood-2024-211122

Published: 2024

Journal Articles

Talicabtagene Autoleucel (humanized CD19 CAR-T) As a Second Line Therapy in r/r B-Cell Lymphoma: Sub-Analysis from a Phase I/II Trial

Blood (2024) 144 (Supplement 1): 7203.

https://doi.org/10.1182/blood-2024-201984

Published: 2024

Journal Articles

Real-World Outcomes with Intensive Chemotherapy in Acute Myeloid Leukemia Patients Deemed “Unfit” for Remission Induction By Landmark Trials' Criteria

Thomas Eipe, Hasmukh Jain, Manju Sengar, Bhausaheb Bagal, Lingaraj Nayak, Alok Shetty

Blood (2023) 142 (Supplement 1): 2442.

https://doi.org/10.1182/blood-2023-188787

Published: 2023

Journal Articles

Hepatitis B Reactivation without Hepatitis Is a Common Event in Adolescent/Adult Patients of Acute Lymphoblastic Leukemia with Occult Hepatitis B (OHBI) Treated on Pediatric Protocols and Warrants Prophylactic Antivirals: A Prospective Cohort Study

Devanshee Shah, Hasmukh Jain, Prachi Patil, Netra Ghandade, Sanjay Biswas, Gaurav Salunkhe, Lingaraj Nayak, Bhausaheb Bagal, Neha Sharma, Manju Sengar

Blood (2023) 142 (Supplement 1): 1459.

https://doi.org/10.1182/blood-2023-181038

Published: 2023

Journal Articles

Outcomes and Prognostic Factors in Patients with Primary Mediastinal B Cell Lymphoma: An Experience from Hematology Cancer Consortium

Akhil Rajendra, Alok Shetty, Anu Korula, Hasmukh Jain, Mobin Paul, Prasanth Ganesan, Jayachandran Perumal Kalaiyarasi, Santhosh Kumar Devadas, Sushil Selvarajan, Abhilash Menon, Divya K, Parathan Karunakaran, Lingaraj Nayak, Om Prakash, Bhausaheb Bagal, Aby Abraham, Prasanna Samuel, Uday Kulkarni

Blood (2023) 142 (Supplement 1): 3141.

https://doi.org/10.1182/blood-2023-186670

Published: 2023

Journal Articles

Excellent Safety Profile of a Low-Cost Novel Humanized CD19 CAR T-Cell Therapy, Actalycabtagene Autoleucel : Potential Impact on Access and Feasibility

Blood (2023) 142 (Supplement 1): 257.

https://doi.org/10.1182/blood-2023-177594

Published: 2023

Journal Articles

Mixed Phenotypic Acute Leukemia -Clinical Presentation, Prognosis and Outcomes of Patients Treated with Acute Lymphoblastic Leukemia like Protocols a Multi-Institutional Study from India

Santhosh Kumar Devadas, Venkatesh Kapu, Lingaraj Nayak, Bhausaheb Bagal, Prashant Tembhare, Aby Abraham, Rajan Kapoor, Jina Bhattacharyya, Parathan Karunakaran, Smitha Carol Saldanha, Smita Kayal, Sharat Damodar, Punit Jain, Om Prakash, Mobin Paul, J John Samuel, Prasanna Samuel

Blood (2023) 142 (Supplement 1): 1463.

https://doi.org/10.1182/blood-2023-187923

Published: 2023

Journal Articles

A Multicenter Retrospective Study to Understand the Clinical Characteristics, Treatment Patterns, and Resource Utilization for Patients with Chronic Lymphocytic Leukemia: CREEK Study

Ahmad Alhuraiji, Ayman Alhejazi, Mohamed Samra, Bhausaheb Bagal, Miguel Arturo Pavlovsky, Macarena Roa, Shang-Ju Wu, Efreen H Montano Figueroa, Veena Selvaratnam, Chee-Yen Lin, Pushpalata K, Akemi Ishikawa, Francisco Gonzalez Hernandez

Blood (2023) 142 (Supplement 1): 3277.

https://doi.org/10.1182/blood-2023-189992

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Double Trouble: Composite Mutations in Driver Genes in Acute Myeloid Leukemia (AML)

Making Treatment Free Remission “Feasible” in Low- and Middle- Income Countries - Outcomes, Patterns of Failure and Compliance of Treatment Free Remission (TFR) in Chronic Myeloid Leukemia (CML) from a Tertiary Care Cancer Centre in India

Real World Data of Novel Talicabtagene Autoleucel (humanized CD19 CAR-T) from India; Ensuring Equitable Access with Excellent Safety and Efficacy Profile

Leukemic Stem Cell Measurable Residual Disease (LSC MRD) Status Is a Better Predictor of Relapse Than Multiparametric Flowcytometric Analysis in Acute Myeloid Leukemia Patients

Machine Learning Identifies Gene Mutations and Variant Allele Fractions That Refine the 2022 European Leukemianet Risk Stratification for Acute Myeloid Leukemia

Diagnostic Value, Predictive Significance and Kinetics of Fecal Calprotectin in Suspected Acute Gut Gvhd / Gvhd Flare Post Allogeneic Stem Cell Transplant

Validation of the 2022 European Leukemianet Risk Stratification of Acute Myeloid Leukemia (AML)

Mutational Landscape and Factors Affecting Prognosis in Acute Myeloid Leukaemia (AML) with RUNX1::RUNX1T1

Prognostic Significance of Wilms' Tumor 1 Gene Mutations in Acute Myeloid Leukemia: Risk Stratification and Survival Outcomes

Myelodysplasia-Related Mutations in Adults and End-of-Induction Measurable Residual Disease Are Associated with Inferior Outcome in Patients with Acute Leukemia of Ambiguous Lineage

Quantitation of Leukemic Stem Cell-like Cells (LSC) Burden at Diagnosis Identifies Clinical Heterogeneity in the ELN22 Risk Stratification of Acute Myeloid Leukemia (AML)

NPM1 Mutated AML with Concurrent DNMT3A Mutation, and FLT3 -Internal Tandem Duplication Has Outcomes Similar to European Leukemianet Adverse Risk Category

Early Immune Reconstitution Post Allogeneic Transplant and Its Impact on Outcomes According to Type of Transplant

Talicabtagene Autoleucel (humanized CD19 CAR-T) As a Second Line Therapy in r/r B-Cell Lymphoma: Sub-Analysis from a Phase I/II Trial

Real-World Outcomes with Intensive Chemotherapy in Acute Myeloid Leukemia Patients Deemed “Unfit” for Remission Induction By Landmark Trials' Criteria

Hepatitis B Reactivation without Hepatitis Is a Common Event in Adolescent/Adult Patients of Acute Lymphoblastic Leukemia with Occult Hepatitis B (OHBI) Treated on Pediatric Protocols and Warrants Prophylactic Antivirals: A Prospective Cohort Study

Outcomes and Prognostic Factors in Patients with Primary Mediastinal B Cell Lymphoma: An Experience from Hematology Cancer Consortium

Excellent Safety Profile of a Low-Cost Novel Humanized CD19 CAR T-Cell Therapy, Actalycabtagene Autoleucel : Potential Impact on Access and Feasibility

Mixed Phenotypic Acute Leukemia -Clinical Presentation, Prognosis and Outcomes of Patients Treated with Acute Lymphoblastic Leukemia like Protocols a Multi-Institutional Study from India

A Multicenter Retrospective Study to Understand the Clinical Characteristics, Treatment Patterns, and Resource Utilization for Patients with Chronic Lymphocytic Leukemia: CREEK Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only